mRNA Cancer Immunotherapies

  • HI-TRON Mainz
  • Immunology, Infection and Cancer
Employee image

Prof. Dr. Ugur Sahin

Immunotherapy revolutionized cancer treatment, but remains limited in solid tumors such as pancreatic and MSS colorectal cancer. The mRNA-LNP technology opens new avenues by leveraging the versatility and adjuvant properties of mRNA to fine-tune immunomodulation and enhance immunostimulatory effects in the tumor microenvironment.

Logo DKFZ

Our Research

The image shows a laboratory setting featuring a sunscreen manufacturing machine labeled "sunscreen" from Lichained Labs. The device includes several connected components and tubes for processing. In the background, there's a computer monitor and glass containers, indicating a scientific workspace.
Lipid nanoparticle formulation device

Our lab conducts research on "mRNA cancer immunotherapies", including antigen-specific immunotherapies using both antibody- and T-cell-based approaches. In addition to classical laboratory techniques, the focus is on sequencing techniques and bioinformatics methods. The aim is - in line with the philosophy of HI-TRON Mainz - to promote the rapid transfer of laboratory research into the clinic.

Team

  • Employee image

    Prof. Dr. Ugur Sahin

  • Employee image

    Dr. Alexandra Alves Duarte

  • Employee image

    Dr. Costanza Zanetti

  • Employee image

    Dr. Sakshi Singh

  • Employee image

    Dr. Jannis Wißfeld

  • Employee image

    Dr. Akhil Velluva

  • A smiling man with a short beard and glasses, wearing a knitted sweater, is facing the camera. He appears friendly and relaxed, set against a background with abstract artwork.

    Dr. Thomas Kerzel-Gnaneswaran

  • Employee image

    Jule Dettweiler

Selected Publications

2024 - Cancer Cell
2022 - Nature Biotechnology
2020 - Nature

Get in touch with us

Employee image

Dr. Alexandra Alves Duarte

Form

Form data is loaded ...